chr7-66086763-C-G

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP2PP3_StrongPP5

The NM_000048.4(ASL):​c.544C>G​(p.Arg182Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000207 in 1,451,352 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R182Q) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

ASL
NM_000048.4 missense

Scores

10
7
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:1

Conservation

PhyloP100: 3.46

Publications

0 publications found
Variant links:
Genes affected
ASL (HGNC:746): (argininosuccinate lyase) This gene encodes a member of the lyase 1 family. The encoded protein forms a cytosolic homotetramer and primarily catalyzes the reversible hydrolytic cleavage of argininosuccinate into arginine and fumarate, an essential step in the liver in detoxifying ammonia via the urea cycle. Mutations in this gene result in the autosomal recessive disorder argininosuccinic aciduria, or argininosuccinic acid lyase deficiency. A nontranscribed pseudogene is also located on the long arm of chromosome 22. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
ASL Gene-Disease associations (from GenCC):
  • argininosuccinic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_000048.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr7-66086764-G-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 203613.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 95 curated pathogenic missense variants (we use a threshold of 10). The gene has 10 curated benign missense variants. Gene score misZ: 0.7488 (below the threshold of 3.09). Trascript score misZ: 1.388 (below the threshold of 3.09). GenCC associations: The gene is linked to argininosuccinic aciduria.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.961
PP5
Variant 7-66086763-C-G is Pathogenic according to our data. Variant chr7-66086763-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 2735029.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASLNM_000048.4 linkc.544C>G p.Arg182Gly missense_variant Exon 8 of 17 ENST00000304874.14 NP_000039.2 P04424-1A0A024RDL8
ASLNM_001024943.2 linkc.544C>G p.Arg182Gly missense_variant Exon 7 of 16 NP_001020114.1 P04424-1A0A024RDL8
ASLNM_001024944.2 linkc.544C>G p.Arg182Gly missense_variant Exon 7 of 15 NP_001020115.1 P04424-2
ASLNM_001024946.2 linkc.524+101C>G intron_variant Intron 6 of 14 NP_001020117.1 A0A0S2Z316

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASLENST00000304874.14 linkc.544C>G p.Arg182Gly missense_variant Exon 8 of 17 1 NM_000048.4 ENSP00000307188.9 P04424-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000207
AC:
3
AN:
1451352
Hom.:
0
Cov.:
32
AF XY:
0.00000416
AC XY:
3
AN XY:
721352
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33310
American (AMR)
AF:
0.00
AC:
0
AN:
42834
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25866
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39236
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85004
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51764
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.00000271
AC:
3
AN:
1107580
Other (OTH)
AF:
0.00
AC:
0
AN:
59998
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Argininosuccinate lyase deficiency Pathogenic:2
Apr 11, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant disrupts the p.Arg182 amino acid residue in ASL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19703900, 24166829; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ASL protein function. This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 182 of the ASL protein (p.Arg182Gly). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ASL-related conditions. -

May 01, 2025
Natera, Inc.
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Uncertain:1
Mar 10, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: ASL c.544C>G (p.Arg182Gly) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 228134 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.544C>G has been reported in the literature in individuals affected with Argininosuccinic Aciduria with non informative genotype (example: Balmer_2013, and Al-Jasmi_2016). These report(s) do not provide unequivocal conclusions about association of the variant with Argininosuccinic Aciduria. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26589311, 24166829). ClinVar contains an entry for this variant (Variation ID: 2735029). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.65
BayesDel_addAF
Pathogenic
0.50
D
BayesDel_noAF
Pathogenic
0.48
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.98
D;D;D;.
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.94
.;D;D;D
M_CAP
Pathogenic
0.98
D
MetaRNN
Pathogenic
0.96
D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.4
M;M;.;M
PhyloP100
3.5
PrimateAI
Pathogenic
0.81
D
PROVEAN
Uncertain
-3.8
D;D;D;D
REVEL
Pathogenic
0.98
Sift
Benign
0.14
T;T;T;T
Sift4G
Uncertain
0.053
T;T;D;T
Polyphen
1.0
D;D;.;.
Vest4
0.97
MutPred
0.82
Loss of MoRF binding (P = 0.0149);Loss of MoRF binding (P = 0.0149);.;Loss of MoRF binding (P = 0.0149);
MVP
0.98
MPC
1.0
ClinPred
0.96
D
GERP RS
3.7
Varity_R
0.96
gMVP
0.98
Mutation Taster
=2/98
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs398123126; hg19: chr7-65551750; API